Primary cutaneous follicle centre lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:34, 3 March 2016
|
Primary cutaneous follicle centre lymphoma Microchapters |
|
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary cutaneous follicle centre lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma epidemiology and demographics |
|
FDA on Primary cutaneous follicle centre lymphoma epidemiology and demographics |
|
CDC on Primary cutaneous follicle centre lymphoma epidemiology and demographics |
|
Primary cutaneous follicle centre lymphoma epidemiology and demographics in the news |
|
Blogs on Primary cutaneous follicle centre lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The incidence of primary cutaneous follicle centre lymphoma increases with age; the median age at diagnosis is 51 years. Males are more commonly affected with hepatosplenic T cell lymphoma than females.[1]
Epidemiology and Demographics
Age
The incidence of primary cutaneous follicle centre lymphoma increases with age; the median age at diagnosis is 51 years.[1]
Gender
Males are more commonly affected with primary cutaneous follicle centre lymphoma than females.[1]
References
- ↑ 1.0 1.1 1.2 Primary cutaneous follicle centre lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd549b/. Accessed on March 01, 2016